12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
Healthcare stocks experienced significant movement in Tuesday's after-market session. Gainers included Apellis Pharmaceuticals (APLS), Immix Biopharma (IMMX), Fortress Biotech (FBIO), Beyond Air (XAIR), SenesTech (SNES), and Sonnet BioTherapeutics (SONN). Losers included Renovaro Biosciences (RENB), SeqLL (SQL), Vincerx Pharma (VINC), Poseida Therapeutics (PSTX), Lucy Scientific Discovery (LSDI), and Mesoblast (MESO).
August 22, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apellis Pharmaceuticals stock rose 33.3% to $41.0 during Tuesday's after-market session.
The significant increase in Apellis Pharmaceuticals' stock price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Fortress Biotech shares moved upwards by 9.14% to $0.46.
The rise in Fortress Biotech's share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Immix Biopharma stock increased by 13.33% to $2.04.
The increase in Immix Biopharma's stock price suggests positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
SenesTech shares moved upwards by 8.41% to $0.76.
The rise in SenesTech's share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
Sonnet BioTherapeutics shares moved upwards by 8.26% to $0.3.
The increase in Sonnet BioTherapeutics' share price suggests positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
Beyond Air shares moved upwards by 9.05% to $2.89.
The increase in Beyond Air's share price suggests positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Lucy Scientific Discovery stock declined by 7.05% to $0.63.
The decline in Lucy Scientific Discovery's stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Mesoblast shares declined by 5.41% to $1.4.
The decline in Mesoblast's share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Poseida Therapeutics stock decreased by 7.07% to $2.34.
The decrease in Poseida Therapeutics' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Renovaro Biosciences stock decreased by 9.8% to $1.94.
The decrease in Renovaro Biosciences' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
SeqLL stock decreased by 8.29% to $0.32.
The decrease in SeqLL's stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Vincerx Pharma stock fell 7.61% to $0.85.
The fall in Vincerx Pharma's stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100